HELP     Sign In

15q23-q24.1CNV Type: Deletion


Largest CNV size: 5057128 bp

Statistics Box:
Number of Reports: 9



Summary Information

Summary statement in development

Additional Locus Information

Genome browsers

USCS Symbol             NCBI Symbol

Decipher

            Decipher Symbol

References

Major Reports

Title
Author, Year
Report Class
CNV Type
A large-scale survey of the novel 15q24 microdeletion syndrome in autism spectrum disorders identifies an atypical deletion that narrows the critic...
Deletion
Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism.
Deletion
Rare de novo and transmitted copy-number variation in autistic spectrum disorders.
Deletion
An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabili...
Deletion-Duplication
Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder.
Deletion

Minor Reports

Title
Author, Year
Report Class
CNV Type
Relative burden of large CNVs on a range of neurodevelopmental phenotypes.
Deletion
Unmasking a novel disease gene NEO1 associated with autism spectrum disorders by a hemizygous deletion on chromosome 15 and a functional polymorphism.
Deletion
Diagnostic yield of array CGH in patients with autism spectrum disorder in Hong Kong.
Deletion
Paternally inherited cis-regulatory structural variants are associated with autism.
Deletion

Cases

Cohort ID
Author, Year
Descripton
Cohort Size
Diagnosis
Age
Gender
CNV Size
Deletion
Duplication
Total CNV's
 brandler_18_ASD_replication_cases
 Affected individuals from MSSNG cohort (1395 cases from 1187 families) and the Simons Simplex 2 (SSC2) cohort (584 cases from simplex quad families)
 1979
 Cases diagnosed with ASD
 N/A
 N/A
 5051820
 1
 0
 1
 girirajan_11_ASD_discovery_cases
 ASD cases with sporadic autism from the Simons Simplex Collection (SSC)
 336
 Diagnosis of ASD based on meeting criteria on ADOS, ADI-R, and expert clinical judgment. 246 cases with no intellectual disability, 90 cases with intellectual disability. Exclusion criteria: significant hearing, vision, or motor problems; significant birth complications; a diagnosis of ASD-related disorders, such as Fragile X; or having a relative (up to 3rd degree) with ASD or sibling showing ASD-related symptoms.
 
 
 5090833
 1
 0
 1
 girirajan_13a_ASD_discovery_cases
 1979 simplex cases from the Simons Simplex Collection (SSC), 579 multiplex cases from AGRE.
 2588
 Diagnosis of ASD based on meeting criteria on the Autism Diagnostic Observation Schedule (ADOS) and on the Autism Diagnostic Interview, Revised (ADI-R)
 NA
 NA
 5047547
 1
 0
 1
 girirajan_13a_DD_discovery_cases
 Data from individuals with developmental delay derived from two published reports (Cooper et al., 2011 & Kaminsky et al., 2011)
 31518
 Developmental delay
 NA
 NA
 0
 0
 0
 0
 kaminsky_11_DD/ID/ASD_discovery_cases
 Cases from the International Standards for Cytogenomic Arrays (ISCA) consortium
 15749
 Unexplained developmental delay, intellectual disability, dysmorphic features, multiple congenital anomalies, autism spectrum disorders, or clinical features suggestive of a chromosomal syndrome
 NA
 NA
 4992764
 1
 1
 2
 levy_11_ASD_discovery_cases
 Autistic probands from 887 families from the Simons Simplex Collection (SSC)
 858
 ASD
 
 87.06% Male
 5052436
 1
 0
 1
 mcinnes_10_ASD_discovery_cases
 Sporadic ASD cases from an isolated founder population in the Central Valley of Costa Rica
 173
 ASD
 
 88.4% Male
 3060000
 1
 0
 1
 sanders_11_ASD_discovery_cases
 Autistic probands from the Simons Simplex Collection (SSC). 872 probands in quartet families, 272 probands in trios.
 1124
 ASD diagnosis: 89.5% autism; 8.5% PDD-NOS, 2% Asperger syndrome. Mean full-scale IQ 85.1 1.5 (mean verbal IQ, 81.9 1.7; mean non-verbal IQ, 88.4 1.4)
 Mean, 9.1 yrs.
 86.1% Male
 5057128
 1
 0
 1
 siu_15_ASD_discovery_cases
 Adult group of 41 ASD cases (39 males, 2 females; age range of 22-33 years, median age 27 years) and pediatric group of 25 ASD cases (21 males, 6 females; age range 2-15 years, median age 5 years)
 66
 All cases diagnosed with ASD. Diagnosis of ASD in adult group confirmed with the Developmental, Dimensional and Diagnostic Interview; adult cohort also assessed with Wechseler Adult Intelligence Scale-Third Edition (WAIS-III). Pediatric group assessed using ADI-R to confirm ASD diagnosis; 13 patients in this group also had developmental delay.
 Range, 2-33 yrs.
 89.39% Male
 1970000
 1
 0
 1
 siu_16_ASD_discovery_cases
 41 adult ASD cases (39 males, 2 females, age range of 22-33 years, median age of 27 years) recruited from a cohort of a local study on the adult outcome of children with autism with normal intelligence, and 27 pediatric ASD cases (21 males, 6 females, age range of 2-15 years, median age of 5 years) assessed in the Department of Paediatrics and Adolescent Medicine of Princess Margaret Hospital or T
 68
 Diagnosis of ASD in cases from the adult cohort was made during childhood (before the year 1990) using Diagnostic and Statistical Manual of Mental Disorders, Third Revised Edition and was confirmed with the developmental, dimensional and diagnostic interview during adulthood; diangosis of ASD in cases from the pediatric cohort was confirmed using ADI-R. IQ of cases in the adult cohort was assessed by Wechsler Adult Intelligence Scale-Third edition (WAIS-III) Chinese version. Developmental delay reported in 13/27 (52.0%) of cases in the pediatric cohort.
 Range, 2-33 yrs. (median age of 25 yrs.)
 88.23% Male
 1970000
 1
 0
 1

Controls

Cohort ID
Author, Year
Descripton
Cohort Size
Diagnosis
Age
Gender
CNV Size
Deletion
Duplication
Total CNV's
 girirajan_11_ASD_discovery_controls
 Control individuals ascertained by NIMH Genetics Initiative. DNA samples from these individuals were obtained from the Rutgers Univ. Cell & DNA Repository.
 337
 Control. Individuals screened specifically for eight mental health disorders.
 
 
 5090833
 0
 0
 0
 girirajan_13a_ASD_discovery_controls3
 Controls assessed for CNVs within 120 SD-mediated hotspots; includes 2090 controls from Wellcome Trust Case-Control Consortium (girirajan_13_ASD_discovery_controls2)
 8329
 Control
 NA
 NA
 0
 0
 0
 0
 kaminsky_11_DD/ID/ASD_discovery_controls
 Controls from the International Standards for Cytogenomic Arrays (ISCA) consortium
 10118
 Controls
 NA
 NA
 NA
 NA
 NA
 NA
 levy_11_ASD_discovery_controls
 Unaffected siblings of autistic probands from 887 families from the Simons Simplex Collection (SSC)
 863
 Control
 
 47.97% Male
 0
 0
 0
 0
 sanders_11_ASD_discovery_controls
 Matched siblings of autistic probands from the Simons Simplex Collection (SSC).
 872
 Controls
 Mean, 10.0 yrs.
 
 0
 0
 0
 0

Cases

Cohort ID
Geographical Ancestry
Discovery Method
Platform
Algorithm
Software
Validation Method
 brandler_18_ASD_replication_cases
  N/A
 WGS
  Illumina HiSeq X10
 ForestSV, Lumpy, Manta, Mobster, SV2
 
 None
 girirajan_11_ASD_discovery_cases
 
 aCGH
  Custom microarray targeting 107 genomic hotspot regions (Roche NimbleGen Hotspot v1.0 array; 12 x 135K)
 HMM
 
 None
 girirajan_13a_ASD_discovery_cases
  NA
 aCGH
  Custom microarray with a high density of probes targeted to 1,367 regions with a susceptible genomic architecture
 ADM-2
 Agilent Genomic Workbench
 aCGH (NimbleGen 135K array)
 girirajan_13a_DD_discovery_cases
  NA
 N/A
  N/A
 
 
 None
 kaminsky_11_DD/ID/ASD_discovery_cases
  NA
 aCGH
  Agilent 44K, Agilent 105K
 
 Feature Extraction, DNA Analytics
 FISH, qPCR, MLPA, aCGH, standard G-banded chromosome analysis
 levy_11_ASD_discovery_cases
 
 aCGH
  NimbleGen HD2
 HMM
 
 aCGH (Agilent 244K)
 mcinnes_10_ASD_discovery_cases
  Costa Rican
 Array SNP
  Affymetrix NspI 250K arrays
 
 
 aCGH, qPCR
 sanders_11_ASD_discovery_cases
  White non-Hispanic, 74.5%; mixed, 9.3%, Asian, 4.3%, White Hispanic, 4.0%, African-American, 3.8%; other, 4.2&
 Solid phase hybridization
  Illumina 1M v1, Illumina 1M v3
 PennCNV, QuantiSNP, GNOSIS
 
 qPCR
 siu_15_ASD_discovery_cases
  Han Chinese
 aCGH
  NimbleGen CGX-135K
 
 DEVA (Roche), Genoglyphix (Signature Genomics)
 
 siu_16_ASD_discovery_cases
  Hong Kong
 aCGH
  NimbleGen CGX-135K
 
 DEVA, Genoglyphix
 None

Controls

Cohort ID
Geographical Ancestry
Discovery Method
Platform
Algorithm
Software
Validation Method
  girirajan_11_ASD_discovery_controls
 
  aCGH
  Custom microarray targeting 107 genomic hotspot regions (Roche NimbleGen Hotspot v1.0 array; 12 x 135K)
  HMM
 
 
  girirajan_13a_ASD_discovery_controls3
  NA
  Array SNP
  N/A
 
 
  None
  kaminsky_11_DD/ID/ASD_discovery_controls
  NA
  aCGH
  Agilent 44K, Agilent 105K
 
  Feature Extraction, DNA Analytics
 
  levy_11_ASD_discovery_controls
 
  aCGH
  NimbleGen HD2
  HMM
 
 
  sanders_11_ASD_discovery_controls
 
  Solid phase hybridization
  Illumina 1M v1 or Illumina 1M v3
  PennCNV, QuantiSNP, GNOSIS
 
 

Cases

Patient ID
Author, Year
Age
Gender
Primary Diagnosis
Clinical Profile
Cognitive Profile
CNV Start
CNV End
CNV Size
Genome Build
Type Method
Validation
  brandler_18_ASD_replication_cases-caseSSC00263
 N/A
 F
 ASD
 Case from SSC_phase2 cohort
 
 68807392
 73859209
  5051818
 GRCh38
 Deletion
 No
  girirajan_11_ASD_discovery_cases-Si169
 9
 F
 Autism
 ADOS score: 10. Vineland composite score: 57.
 Mild mental retardation/intellectual disability. Full-scale IQ, 57; Verbal IQ, 65; Non-verbal IQ, 60.
 68802337
 73893169
  5090833
 GRCh38
 Deletion
 No
  girirajan_13a_ASD_discovery_cases-11233.p1
 N/A
 N/A
 ASD
 Diagnosis of ASD based on meeting criteria on the Autism Diagnostic Observation Schedule (ADOS) and on the Autism Diagnostic Interview, Revised (ADI-R)
 N/A
 68811476
 73859022
  5047547
 GRCh38
 Deletion
 Yes
  kaminsky_11_DD/ID/ASD_discovery_cases-ISCA00000800
 NA
 NA
 Developmental delay/intellectual disability/ASD
 Clinical profile NA
 Cognitive profile NA
 68830574
 73823337
  4992764
 GRCh38
 Deletion
 Yes
  kaminsky_11_DD/ID/ASD_discovery_cases-ISCA00001996
 NA
 NA
 Developmental delay/intellectual disability/ASD
 Clinical profile NA
 Cognitive profile NA
 72058544
 72481033
  422490
 GRCh38
 Duplication
 Yes
  levy_11_ASD_discovery_cases-11233.p1
 NA
 F
 ASD
 NA
 NA
 68807208
 73859642
  5052435
 GRCh38
 Deletion
 Yes
  mcinnes_10_ASD_discovery_cases-AU008
 5
 M
 Autism
 Behavioral abnormalities: developmental regression, constant smiling, hyperactivity, aggressiveness, sleep disturbances. Neurological abnormalities: minimal cortical atrophy on CT, hypotonia not reported but probable. Growth: low birth weight, no persistent growth retardation, obesity, or low head circumference. Facial dysmorphism: high anterior hair line, long narrow face, hypertelorism, broad medial eyebrows, epicanthus, full lower lip, widely spaced teeth, protuberant ears. Eye abnormalities: nystagmus. Digital abnormalities: right single palmar crease, left 2-3 syndactyly of toes. Mild scoliosis and joint laxity, polyhydramminos, recurrent infections.
 Moderate intellectual disability; language regression, 2 words at 5 yrs
 71758583
 74817543
  3058961
 GRCh38
 Deletion
 Yes
  sanders_11_ASD_discovery_cases-11233.p1
 6.3
 F
 Autism
 NA
 Full-scale IQ, 57; non-verbal IQ, 60; verbal IQ, 65
 68807678
 73864805
  5057128
 GRCh38
 Deletion
 Yes
  siu_15_ASD_discovery_cases-case1
 26 yrs.
 M
 Autism
 Case diagnosed with autism at age of 3 years (diagnosis confirmed with Developmental, Dimensional and Diagnostic Interview during adulthood). Birth/neonatal history: born at full-term without complications. Developmental milestones: developmental delays; could not walk independently until 24 months old, spoke first meaningful words after 24 months of age. Language and communication evaluation: impairments in social interactions and communication with other people. Motor and musculoskeletal evaluation: no abnormalities affecting digits or skeletal system. Behavioral/psychiatric evaluation: described as having a difficult temper; displayed stereotypies, including clapping and hand scratching. Epilepsy/seizures: none. Dysmorphic features: mild hypertelorism, broad nasal bade, mild facial asymmetry. Family history: non-consanguineous parents; father was 32 and mother 29 at time of birth; father N/A for testing; both unaffected mother and younger sister are negative for deletion; no other autistic family members.
 Mild intellectual disability
 71391645
 73360338
  1968694
 GRCh38
 Deletion
 No
  siu_16_ASD_discovery_cases-patient3
 Adult (22-33 yrs.)
 M
 ASD
 Diagnosis of ASD made during childhood (before the year 1990) using Diagnostic and Statistical Manual of Mental Disorders, Third Revised Edition and confirmed with the developmental, dimensional and diagnostic interview during adulthood. Additional clinical features: subtle facial dysmorphism.
 IQ of 85 [as determined by Wechsler Adult Intelligence Scale-Third edition (WAIS-III) Chinese version]
 71391645
 73360338
  1968694
 GRCh38
 Deletion
 No

Controls

No Control Data Available

Cases

Patient ID
Validation Description
Primary Disorder Inheritence
Inheritence
Family Profile
Disease Segregation
Gene Content
Altered Gene Expression
 brandler_18_ASD_replication_cases-caseSSC00263
 No validation step reported
 
 De novo
 
 
 RPLP1,MIR629,RNU6-745P,LINC02205,SALRNA3,SALRNA2,RPL29P30,KRT8P9,THAP10,RPL5P3,CT62,HMGB1P6,RNA5SP399,EIF5A2P1,RNU2-65P,HEXA-AS1,RPL12P35,PHBP20,MIR630,RN7SL853P,NPM1P42,FKBP1AP2,NPM1P43,MRPS15P1,NPTN-IT1,KIF23,TLE3,LINC02204,UACA,LARP6,NR2E3,SENP8,GRAMD2A,PARP6,CELF6,TMEM202,TMEM202-AS1,GOLGA6B,HIGD2B,BBS4,ADPGK,ADPGK-AS1,HCN4,NPTN,CD276,INSYN1,INSYN1-AS1,ANP32A,SPESP1,NOX5,EWSAT1,PAQR5,DRAIC,LRRC49,THSD4-AS1,MYO9A,PKM,ARIH1,LINC02259,NEO1,REC114,GLCE,THSD4,HEXA
 
 girirajan_11_ASD_discovery_cases-Si169
 
 
 De novo
 Simplex
 
 RPLP1,MIR629,RNU6-745P,LINC02205,SALRNA3,SALRNA2,RPL29P30,KRT8P9,THAP10,RPL5P3,CT62,HMGB1P6,RNA5SP399,EIF5A2P1,RNU2-65P,HEXA-AS1,RPL12P35,PHBP20,MIR630,RN7SL853P,NPM1P42,FKBP1AP2,NPM1P43,MRPS15P1,NPTN-IT1,KIF23,TLE3,LINC02204,UACA,LARP6,NR2E3,SENP8,GRAMD2A,PARP6,CELF6,TMEM202,TMEM202-AS1,GOLGA6B,HIGD2B,BBS4,ADPGK,ADPGK-AS1,HCN4,NPTN,CD276,INSYN1,INSYN1-AS1,TBC1D21,ANP32A,SPESP1,NOX5,EWSAT1,PAQR5,DRAIC,LRRC49,THSD4-AS1,MYO9A,PKM,ARIH1,LINC02259,NEO1,REC114,GLCE,THSD4,HEXA
 
 girirajan_13a_ASD_discovery_cases-11233.p1
 aCGH (NimbleGen 135K array)
 
 De novo
 Simplex
 Possibly segregated
 RPLP1,MIR629,RNU6-745P,LINC02205,SALRNA3,SALRNA2,RPL29P30,KRT8P9,THAP10,RPL5P3,CT62,HMGB1P6,RNA5SP399,EIF5A2P1,RNU2-65P,HEXA-AS1,RPL12P35,PHBP20,MIR630,RN7SL853P,NPM1P42,FKBP1AP2,NPM1P43,MRPS15P1,NPTN-IT1,KIF23,TLE3,LINC02204,UACA,LARP6,NR2E3,SENP8,GRAMD2A,PARP6,CELF6,TMEM202,TMEM202-AS1,GOLGA6B,HIGD2B,BBS4,ADPGK,ADPGK-AS1,HCN4,NPTN,CD276,INSYN1,INSYN1-AS1,ANP32A,SPESP1,NOX5,EWSAT1,PAQR5,DRAIC,LRRC49,THSD4-AS1,MYO9A,PKM,ARIH1,LINC02259,NEO1,REC114,GLCE,THSD4,HEXA
 
 kaminsky_11_DD/ID/ASD_discovery_cases-ISCA00000800
 FISH, qPCR, MLPA, aCGH, or standard G-banded chromosome analysis
 
 De novo
 Unknown
 Unknown
 RPLP1,MIR629,RNU6-745P,LINC02205,SALRNA3,SALRNA2,RPL29P30,KRT8P9,THAP10,RPL5P3,CT62,HMGB1P6,RNA5SP399,EIF5A2P1,RNU2-65P,HEXA-AS1,RPL12P35,PHBP20,MIR630,RN7SL853P,NPM1P42,FKBP1AP2,NPM1P43,MRPS15P1,NPTN-IT1,KIF23,TLE3,LINC02204,UACA,LARP6,NR2E3,SENP8,GRAMD2A,PARP6,CELF6,TMEM202,TMEM202-AS1,GOLGA6B,HIGD2B,BBS4,ADPGK,ADPGK-AS1,HCN4,NPTN,CD276,INSYN1,INSYN1-AS1,SPESP1,NOX5,EWSAT1,PAQR5,DRAIC,LRRC49,THSD4-AS1,MYO9A,PKM,ARIH1,LINC02259,NEO1,REC114,GLCE,THSD4,HEXA
 
 kaminsky_11_DD/ID/ASD_discovery_cases-ISCA00001996
 FISH, qPCR, MLPA, aCGH, or standard G-banded chromosome analysis
 
 Unknown
 Unknown
 Unknown
 HEXA-AS1,RPL12P35,PHBP20,SENP8,GRAMD2A,PARP6,CELF6,TMEM202,TMEM202-AS1,MYO9A,PKM,ARIH1,HEXA
 
 levy_11_ASD_discovery_cases-11233.p1
 aCGH (Agilent 244K)
 
 De novo
 Simplex
 Segregated
 RPLP1,MIR629,RNU6-745P,LINC02205,SALRNA3,SALRNA2,RPL29P30,KRT8P9,THAP10,RPL5P3,CT62,HMGB1P6,RNA5SP399,EIF5A2P1,RNU2-65P,HEXA-AS1,RPL12P35,PHBP20,MIR630,RN7SL853P,NPM1P42,FKBP1AP2,NPM1P43,MRPS15P1,NPTN-IT1,KIF23,TLE3,LINC02204,UACA,LARP6,NR2E3,SENP8,GRAMD2A,PARP6,CELF6,TMEM202,TMEM202-AS1,GOLGA6B,HIGD2B,BBS4,ADPGK,ADPGK-AS1,HCN4,NPTN,CD276,INSYN1,INSYN1-AS1,ANP32A,SPESP1,NOX5,EWSAT1,PAQR5,DRAIC,LRRC49,THSD4-AS1,MYO9A,PKM,ARIH1,LINC02259,NEO1,REC114,GLCE,THSD4,HEXA
 
 mcinnes_10_ASD_discovery_cases-AU008
 aCGH, qPCR
 
 Paternal
 Simplex
 NA
 RNA5SP399,EIF5A2P1,RNU2-65P,HEXA-AS1,RPL12P35,PHBP20,MIR630,RN7SL853P,NPM1P42,FKBP1AP2,NPM1P43,MRPS15P1,NPTN-IT1,DNM1P33,RN7SL429P,ISLR,PPIAP46,MIR6881,CYP1A1,CYP1A2,MIR4513,NR2E3,SENP8,GRAMD2A,PARP6,CELF6,TMEM202,TMEM202-AS1,GOLGA6B,HIGD2B,BBS4,ADPGK,ADPGK-AS1,HCN4,NPTN,CD276,INSYN1,INSYN1-AS1,TBC1D21,LOXL1,STOML1,PML,GOLGA6A,ISLR2,CYP11A1,LINC02255,SEMA7A,UBL7-AS1,CLK3,EDC3,CSK,LMAN1L,MYO9A,PKM,ARIH1,LINC02259,NEO1,REC114,LOXL1-AS1,STRA6,CCDC33,ARID3B,THSD4,HEXA,UBL7
 
 sanders_11_ASD_discovery_cases-11233.p1
 qPCR
 
 De Novo
 Simplex (quad-proband matched)
 Segregated
 RPLP1,MIR629,RNU6-745P,LINC02205,SALRNA3,SALRNA2,RPL29P30,KRT8P9,THAP10,RPL5P3,CT62,HMGB1P6,RNA5SP399,EIF5A2P1,RNU2-65P,HEXA-AS1,RPL12P35,PHBP20,MIR630,RN7SL853P,NPM1P42,FKBP1AP2,NPM1P43,MRPS15P1,NPTN-IT1,KIF23,TLE3,LINC02204,UACA,LARP6,NR2E3,SENP8,GRAMD2A,PARP6,CELF6,TMEM202,TMEM202-AS1,GOLGA6B,HIGD2B,BBS4,ADPGK,ADPGK-AS1,HCN4,NPTN,CD276,INSYN1,INSYN1-AS1,ANP32A,SPESP1,NOX5,EWSAT1,PAQR5,DRAIC,LRRC49,THSD4-AS1,MYO9A,PKM,ARIH1,LINC02259,NEO1,REC114,GLCE,THSD4,HEXA
 
 siu_15_ASD_discovery_cases-case1
 
 
 Unknown (not maternal)
 Simplex
 Unknown
 RNA5SP399,EIF5A2P1,RNU2-65P,HEXA-AS1,RPL12P35,PHBP20,MIR630,RN7SL853P,NPM1P42,FKBP1AP2,NPM1P43,NR2E3,SENP8,GRAMD2A,PARP6,CELF6,TMEM202,TMEM202-AS1,GOLGA6B,HIGD2B,BBS4,ADPGK,ADPGK-AS1,HCN4,MYO9A,PKM,ARIH1,LINC02259,NEO1,THSD4,HEXA
 
 siu_16_ASD_discovery_cases-patient3
 
 
 Unknown
 Unknown
 Unknown
 RNA5SP399,EIF5A2P1,RNU2-65P,HEXA-AS1,RPL12P35,PHBP20,MIR630,RN7SL853P,NPM1P42,FKBP1AP2,NPM1P43,NR2E3,SENP8,GRAMD2A,PARP6,CELF6,TMEM202,TMEM202-AS1,GOLGA6B,HIGD2B,BBS4,ADPGK,ADPGK-AS1,HCN4,MYO9A,PKM,ARIH1,LINC02259,NEO1,THSD4,HEXA
 

Controls

No Control Data Available
No Animal Model Data Available
HELP
Copyright © 2017 MindSpec, Inc.